Clinical Trial Update: MPDL3280A With Chemoradiation for Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating atezolizumab (MPDL3280A) with chemoradiation for lung cancer (non-small cell lung cancer); current status is active but not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• MPDL3280A (atezolizumab) (atezolizumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lung Cancer, Non-Small Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING